Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ASEAN Business News

DYADIC MANAGEMENT TO SPEAK AT INDUSTRY, INVESTOR EVENTS IN OCTOBER

[ad_1]

KUALA LUMPUR, Oct 2 (Bernama) — Dyadic International Inc (Dyadic), a global biotechnology company has announced its management will be presenting at the industry and investor events during the month of October.

The first event of the month, namely, Enzyme Engineering XXVII will take place from Oct 1 to 6 in Park Royale Hotel, Singapore with presentation by Dyadic Chief Scientific Officer, Dr Ronen Tchelet on the Oct 4.

It will be followed by LD Mirco Main Event XVI (Oct 3-5), in Luxe Sunset Blvd Hotel, Los Angeles, which will be presented by its President and Chief Executive Officer, Mark Emalfarb on Oct 4.

Additionally, Emalfarb will also be presenting at World Vaccine Congress Europe (Oct 16-19), in Fira de Barcelona Montjuic, Barcelona, Spain on Oct 18, according to a statement.

Dyadic focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness.

With a passion to enable its partners and collaborators to develop effective preventative and therapeutic treatments in both developed and emerging countries, Dyadic is building an active pipeline by advancing its proprietary microbial platform technologies.



BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on the Astro 502, unifi TV 631 and MYTV 121 IFLIX channels and BERNAMA Radio on the FM93.9 (Klang Valley), FM107.5 (Johor), FM107.9 (Kota Kinabalu) and RM100.9 (Kuching) frequencies.

Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial

[ad_2]

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button